Glucotrack (GCTK) Cost of Revenue (2016 - 2020)
Glucotrack's Cost of Revenue history spans 5 years, with the latest figure at -$37000.0 for Q4 2020.
- For the quarter ending Q4 2020, Cost of Revenue fell 128.81% year-over-year to -$37000.0, compared with a TTM value of $237000.0 through Dec 2020, down 58.64%, and an annual FY2023 reading of $122000.0, changed N/A over the prior year.
- Cost of Revenue for Q4 2020 was -$37000.0 at Glucotrack, down from $93000.0 in the prior quarter.
- The five-year high for Cost of Revenue was $465814.0 in Q3 2017, with the low at -$916663.0 in Q4 2016.
- Average Cost of Revenue over 5 years is $174965.4, with a median of $236007.5 recorded in 2017.
- Year-over-year, Cost of Revenue skyrocketed 150.3% in 2017 and then crashed 128.81% in 2020.
- Tracing GCTK's Cost of Revenue over 5 years: stood at -$916663.0 in 2016, then skyrocketed by 150.3% to $461120.0 in 2017, then plummeted by 49.02% to $235076.0 in 2018, then crashed by 45.36% to $128445.0 in 2019, then crashed by 128.81% to -$37000.0 in 2020.
- Per Business Quant, the three most recent readings for GCTK's Cost of Revenue are -$37000.0 (Q4 2020), $93000.0 (Q3 2020), and $90000.0 (Q2 2020).